Perventricular device closure of ventricular septal defects: six months results in 30 young children

Changping Gan1, Qi An, Ke Lin

  • 1Department of Thoracic and Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Insights

Perventricular device closure offers a safe and effective option for young children with isolated ventricular septal defects, avoiding cardiopulmonary bypass. This minimally invasive approach shows promising short-term results with high success rates and acceptable outcomes.

Area of Science:

  • Pediatric Cardiology
  • Minimally Invasive Cardiac Surgery
  • Interventional Cardiology

Background:

  • Traditional surgical and transcatheter methods for ventricular septal defects (VSDs) have limitations in pediatric patients.
  • This study focuses on perventricular device closure for nonmuscular VSDs in young children.
  • The technique aims to overcome limitations of existing VSD closure methods.

Purpose of the Study:

  • To evaluate the short-term safety and efficacy of perventricular device closure for isolated nonmuscular VSDs.
  • To assess the outcomes of a minimally invasive approach without cardiopulmonary bypass in pediatric patients.
  • To determine the feasibility of this technique in young children.

Main Methods:

  • Thirty pediatric patients with nonmuscular VSDs underwent perventricular device closure.
  • A minimally invasive subxiphoid incision was used, avoiding cardiopulmonary bypass.
  • Transesophageal echocardiography guided ventricular puncture and device deployment.

Main Results:

  • Successful closure was achieved in 90% (27/30) of patients.
  • No mortality or atrioventricular block occurred during the follow-up period.
  • Minor complications included transient incomplete right bundle branch block and mild tricuspid regurgitation in some patients.

Conclusions:

  • Perventricular device closure is a safe and effective option for selected young children with isolated VSDs.
  • The technique demonstrates acceptable short-term outcomes without the need for cardiopulmonary bypass.
  • This minimally invasive approach offers a viable alternative for pediatric VSD management.
Abstract